2026-05-23T20:19:45Zhttps://keep.lib.asu.edu/oai/requestoai:keep.lib.asu.edu:node-1980822024-12-19T19:04:43Zoai_pmh:alloai_pmh:repo_items198082
https://hdl.handle.net/2286/R.2.N.198082
http://rightsstatements.org/vocab/InC/1.0/
http://creativecommons.org/licenses/by-nc-sa/4.0
2024-12
45 pages
Viton, Rosalia
Kizer, Aidan
Peterson, Kylie
Salter, Martha
Ger, Benjamin
Compton, Carolyn
Iqbal, Aneel
Xie, Man
Larson, David
Barrett, The Honors College
WPC Graduate Programs
School of Accountancy
Department of Information Systems
Text
This chapter offers a comprehensive analysis of the economic factors influencing the HPV vaccine across its lifecycle. It examines critical phases, including research and development, pricing and market dynamics, marketing strategies, supply chain management, and post-market economic impacts on consumers and healthcare providers. By exploring these interconnected stages, the chapter aims to display the economic viability of the HPV vaccine market and its potential long-term benefits. Additionally, the chapter discusses future research directions, particularly in relation to the evolving regulatory landscape and the implications of emerging vaccine technologies.
HPV
Vaccine
Merck
Cancer
Marketing
Supply Chain
Pricing
Cost effectiveness
Market Dynamics
ForkHPV
ForkHPV: The Business and Economics of the HPV Vaccine